Comparative Study of Visual Inspection of Cervix by Acetic Acid Application and Pap Smear Cytology in Screening of Cervical Cancer in Asymptomatic Woman
Authors/Creators
- 1. Assistant Professor, Department of Obstetrics and Gynaecology, Dr Vasantrao Pawar Medical College Hospital and Research Center Adgaon Nashik, Maharashtra
- 2. Associate Professor, Department of Obstetrics and Gynaecology, MIMER Medical College, Talegaon(D), Pune, Maharashtra
- 3. Senior Resident, Department of Obstetrics and Gynaecology, Pravara Institute of Medical Sciences Loni, Taluka Rahata, Dist.- Ahmednagar, Maharashtra
Description
Introduction: In India Cervical cancer is second most common cancer in woman. Every year around 1.23 lakh new cases are diagnosed with cervical cancer and 67,500 of these woman die in India. There are various screening various screening techniques such as visual inspection with acetic acid, visual inspection with Lugol’s iodine, visual inspection with magnification devices-Magna visualizer, Pap smear and HPV-DNA testing have been suggested and tried under low-resource settings of our country, and cervical cytology screening has been found effective in reducing incidence of the disease. Material and Methods: It is prospective observational study. This study was be conducted in the Department of Obstetrics and Gynaecology in medical college and tertiary health centre comprising of woman who are sexually active during 2020 -2022 with sample size of 236. Results: Out of 236 cases, 39.80% were positive and 60.20% were negative according to visual inspection of cervix with acetic acid. According to cytology (Pap smear) reports, 56.8% were normal, 41.6% were inflammatory, 1.2% was having LSIL/ atypical and 0.4% was having HSIL. VIA has, the sensitivity of about 43.58% and specificity of about 41.70%. Pap smear has the sensitivity of about 43.58% and specificity of about 41.70%. Conclusion: Visual inspection with acetic acid is simple and easy. It is effective and can be used as an alternate strategy in low resource settings where screening for cancer cervix by Pap smear is not always possible due to inadequate cytologists.
Abstract (English)
Introduction: In India Cervical cancer is second most common cancer in woman. Every year around 1.23 lakh new cases are diagnosed with cervical cancer and 67,500 of these woman die in India. There are various screening various screening techniques such as visual inspection with acetic acid, visual inspection with Lugol’s iodine, visual inspection with magnification devices-Magna visualizer, Pap smear and HPV-DNA testing have been suggested and tried under low-resource settings of our country, and cervical cytology screening has been found effective in reducing incidence of the disease. Material and Methods: It is prospective observational study. This study was be conducted in the Department of Obstetrics and Gynaecology in medical college and tertiary health centre comprising of woman who are sexually active during 2020 -2022 with sample size of 236. Results: Out of 236 cases, 39.80% were positive and 60.20% were negative according to visual inspection of cervix with acetic acid. According to cytology (Pap smear) reports, 56.8% were normal, 41.6% were inflammatory, 1.2% was having LSIL/ atypical and 0.4% was having HSIL. VIA has, the sensitivity of about 43.58% and specificity of about 41.70%. Pap smear has the sensitivity of about 43.58% and specificity of about 41.70%. Conclusion: Visual inspection with acetic acid is simple and easy. It is effective and can be used as an alternate strategy in low resource settings where screening for cancer cervix by Pap smear is not always possible due to inadequate cytologists.
Files
IJPCR,Vol15,Issue11,Article114.pdf
Files
(432.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:3646f5cc90c0361c7bc951a00b2478a9
|
432.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-10-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue11,Article114.pdf
- Development Status
- Active
References
- 1. World Health Organization. Report on cancer 2018. Accessed on 2019 Dec 12. Accessed from:https://www.who.int/cancer/prevention/di agnosis screening/cervical-cancer/en/ 2. Patil AD, Salvi NR, Shahina B, Pimple AS, Mishra AG, Chauhan LS, Joshi BN. Perspectives of primary healthcare providers on implementing cancer screening services in tribal block of Maharashtra, India. South Asian J Cancer [serial online], 2019 July-Sept, 8(3); 145-49. 3. Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening inrural India: Status and current concepts. Indian J Med Res [serial online], 2018 Dec, 148 (6):687-96. 4. Vinegar test. Wikipedia encyclopedia Accesssed on 2012 Jan 7, Accessed from https://en.wikipedia.org/wiki/Vinegar_test accessed on 12 March 1999. 5. PATH. Global HPV vaccine introduction overview: projected and current national introductions, demonstration/pilot projects, gender-neutral vaccination programs, and global HPV vaccine introduction maps (2006- 2023). PATH; 2020. [Cited on 2020 Nov 23]. Accessed from: https:// path. azureedge. net/media/documents/Global_Vaccine_Intro_O verview_Slides_Final_PATHwebsite_2021AU G17_fx7PZjH.pdf. 6. WHO / ICO HPV information centre on Human Papilloma virus and Related cancers in India. Summary Report Update September. 2010;15: pg 6 & pg 28. 7. Lakshmi Seshadri – Chapter "Premalignant Diseases of the Cervix".1 st ed. In Essentials of Gynecology.pg 374-378. Lippincott Williams and Wilkins 2011. 8. Perkins RB, Guido RS, Castle PE, ASCCP Risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors J Low Genit Tract Dis, 2020;24: 102-31. 9. Munger K, Scheffner M, Hulbregtse JM, et al. Interactions of HPV E6 and E7oncoproteins with tumor suppressor gene products Cancer Surv 1992; 12:197-216. 10. Krishnakumar Duraisamy. K.S.et al: Methods of Detecting Cervical Cancer Advances in Biological Research. 2011; 5(4):226-232. 11. Ashish Kumar Bhattacharyya, Jyan Dip Nath, and Harajyoti Deka Comparative study between Pap smear and visual inspection with acetic acid (via) in screening of CIN and early cervical cancer. J Midlife Health. 2015 AprJun, 6(2): 53–58. 12. Mercy Mrudula Dasari, Venkatalakshmi Anem, Sirisha Gunta, Satish Kumar Seeram, Bhagyalakshmi Atla. Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid for mass screening of lesions of cervix. Int J Res Med Sci. 2018 Jun, 6(6):2042-2048 13. Kamal Patil, G Durdi, KS Lakshmi, MK Swamy Comparison of Diagnostic Efficacy of Visual Inspection of Cervix with Acetic Acid and Pap Smear.Journal of South Asian Federation of Obstetrics and Gynaecology, September-December 2011;3(3):131-134 14. Niyodusenga A, Musoni E, Niyonsaba S. Comparative study of Pap smear test and VIA test in cervical carcinoma screening among women aged over 20 years. Rwanda Journal of Medicine and Health Sciences. 2020 March, 3(1):21-29 15. SO Albert, OA Oguntayo, and MOA Samaila. Ecancer medical science. Comparative study of visual inspection of the cervix using acetic acid (VIA) and Papanicolaou (Pap) smears for cervical cancer screening. 2012; 6: 262. Published online 2012 Jul 23.